Dr. Anthony Chaffee interviews naturopathic doctor Dr. Petra Davelaar. She discusses her work and insights into health, particularly in relation to cancer. Dr. Davelaar explains her journey into this field was sparked by becoming a parent and later intensified by her mother’s colon cancer diagnosis in 2018, following the loss of her father to cancer earlier in her life. This personal experience drove her to research alternative approaches, leading her to discover the potential role of deuterium in disease.
The conversation delves into the significance of deuterium, a stable isotope of hydrogen, and its potential role in cancer. Dr. Davelaar explains that while some deuterium is necessary, high levels in the body, often due to diet and lifestyle, can be detrimental. She notes that ideally, a healthy human would have deuterium levels around 135 parts per million (ppm) in their body water, while individuals with health issues typically have higher levels, with cancer patients often exceeding 150 ppm. Dr. Davelaar discusses methods for lowering deuterium levels, including consuming foods low in deuterium such as fats, animal protein, and green above-ground vegetables, as well as considering deuterium-depleted water for individuals with cancer.
The discussion then shifts to the critical role of the light environment in health. Dr. Davelaar highlights the work of Jack Kruse, explaining that UVA light activates the POMC gene, leading to melanin production, which is crucial for various bodily functions, including metabolic water production and cellular charge. Conversely, artificial blue light is described as detrimental, potentially causing insulin resistance and elevated glucose levels through the same POMC pathway. Dr. Davelaar emphasises the importance of being outdoors, suggesting that even the type of glass in windows can affect the beneficial red light spectrum. She also mentions the potential benefits of infrared light therapy.
Regarding cancer specifically, Dr. Davelaar views it partly as a metabolic and mitochondrial disease, where high deuterium levels can damage mitochondria. The conversation touches upon the controversial topic of antioxidants in cancer treatment, with Dr. Davelaar agreeing with the caution against high-dose vitamin C and synthetic glutathione, as they might protect cancer cells. However, she clarifies that not all compounds with antioxidant properties are necessarily detrimental and highlights ongoing research into specific substances like isocetin. She stresses the importance of a holistic approach to cancer care, advocating for collaboration with oncologists while exploring complementary therapies such as dietary changes, deuterium management, and addressing the light environment.
Finally, the discussion touches on other emerging areas of interest, including the role of nanobubbles and dissolved gases in bodily functions, which Dr. Davelaar finds fascinating and potentially overlooked in traditional medicine. The potential role of anti-parasitic drugs like ivermectin and fenbendazole in cancer treatment is also briefly mentioned, with Dr. Davelaar noting the growing anecdotal evidence and multiple proposed mechanisms of action, although she cannot prescribe them. She concludes by providing her website for those interested in learning more about her work and mentioning an upcoming educational platform focused on cancer awareness and prevention.